Jeff Lamothe
Board Member
Aptevo Therapeutics Inc. (APVO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeff Lamothe
Jeff Lamothe is recorded as Board Member and CEO at Aptevo Therapeutics Inc. (APVO). Aptevo Therapeutics Inc. reported in an 8-K filed February 3, 2026 that Jeff Lamothe was appointed Class III director, effective April 1, 2026. Aptevo Therapeutics Inc. reported in an 8-K filed February 3, 2026 that Jeff Lamothe was appointed President and Chief Executive Officer, effective April 1, 2026.
“the Board has appointed Mr. Lamothe to serve as a Class III director of the Company to hold office until the 2028 annual meeting of stockholders of the Company and a member of the Executive Committee of the Board effective as of the Transition Date.”
“Jeff Lamothe, the Company's current Chief Operating Officer, will assume the role of President and Chief Executive Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-01–present
-
Current
2026-04-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aptevo Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Barbara Lopez Kunz CEO, Board Member
- Daniel J. Abdun-Nabi CEO, Board Member
- Jeffrey G. Lamothe CEO, COO
- Zsolt Harsanyi CEO, Board Member
- John E. Niederhuber Chairman, Board Member
- John Niederhuber, M.D. Chairman
- Marvin L. White Chairman, Board Member
- Daphne Taylor CFO
- SoYoung Kwon General Counsel
- Grady Grant Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.